8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)

Published 19 Oct 2026, 13:01 UTC. Updated 19 Oct 2026, 13:01 UTC.

Filed: 2026-10-19 AccNo: 0001193125-26-424739 Size: 147 KB Item 8.01: Other Events

Directly affected

RARE Ultragenyx Pharmaceutical
Named in this report.

Indirectly affected

SPY SPDR S&P 500
The broad U.S. stock market
TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
QQQ Invesco QQQ
Large technology stocks
GLD SPDR Gold Shares
Gold can move with the broad market

Price reaction, T-5 to T+3

Ticker	T-5	T-3	T-1	T0	T+1	T+2	T+3
RARE	+5.05%	+2.51%	—	+3.57%	+6.60%	—	—
SPY	+1.93%	+0.83%	—	+0.43%	+0.61%	—	—
TLT	-2.51%	-1.44%	—	-0.72%	+0.10%	—	—
QQQ	+5.10%	+2.70%	—	+1.20%	+0.87%	—	—
GLD	+0.03%	-1.59%	—	-0.63%	-0.98%	—	—

Filed: 2026-10-19 AccNo: 0001193125-26-424739 Size: 147 KB Item 8.01: Other Events

Source: sec-edgar

Ultragenyx Pharmaceutical (RARE) since “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer),” compared with the market

Company	When	Move	Status
GLD	that day	-0.63%	final price
GLD	the next day	-0.98%	still updating
GLD	three days earlier	-1.59%	final price
GLD	five days earlier	+0.03%	final price
QQQ	that day	+1.20%	final price
QQQ	the next day	+0.87%	still updating
QQQ	three days earlier	+2.70%	final price
QQQ	five days earlier	+5.10%	final price
Ultragenyx Pharmaceutical (RARE)	that day	+3.57%	final price
Ultragenyx Pharmaceutical (RARE)	the next day	+6.60%	still updating
Ultragenyx Pharmaceutical (RARE)	three days earlier	+2.51%	final price
Ultragenyx Pharmaceutical (RARE)	five days earlier	+5.05%	final price
SPY	that day	+0.43%	final price
SPY	the next day	+0.61%	still updating
SPY	three days earlier	+0.83%	final price
SPY	five days earlier	+1.93%	final price
TLT	that day	-0.72%	final price
TLT	the next day	+0.10%	still updating
TLT	three days earlier	-1.44%	final price
TLT	five days earlier	-2.51%	final price

Disclosure records for Ultragenyx Pharmaceutical (RARE) within two months of 19 Oct 2026

Gilbert Cisneros buy Ultragenyx Pharmaceutical (RARE) ($1,001 - $15,000). That is 20 days before publication, inside 30 days. The filing is listed beside the story “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer).”

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who is named in “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)”

Companies carried with this story

RARE Ultragenyx Pharmaceutical
For “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer),” Ultragenyx Pharmaceutical (RARE) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> RARE

How “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)” reaches Ultragenyx Pharmaceutical (RARE)

On 19 Oct 2026, “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)” is the story that connects Ultragenyx Pharmaceutical (RARE) to this story.

For Ultragenyx Pharmaceutical (RARE), the reason on file says SEC 8-K filing -> direct issuer disclosure -> RARE

Price levels for Ultragenyx Pharmaceutical (RARE)

RARE traded between 12.88 and 15.73 across 11 sessions. The latest close on file is 15.07.

A simple score for Ultragenyx Pharmaceutical (RARE)

44 out of 100Price not final

“8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)” scores 44 out of 100. The score uses 1 sources, a +5.99% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.